QuTEM AB has partnered with the Multiscale Microscopy Core (MMC) at Oregon Health & Science University (OHSU) to establish a new laboratory in Portland, Oregon. This collaboration aims to expand QuTEM’s analytical services across the United States, providing enhanced access to specialized transmission electron microscopy (TEM) services for cell and gene therapy developers on the West Coast. The Portland facility is the company’s second U.S. satellite laboratory, following the launch of its Boston operations earlier this year.
The Portland lab will operate under a model similar to QuTEM’s Boston site, allowing biotechnology companies to submit development-stage samples to a domestic laboratory, reducing the need for international or cross-country shipping. This approach is expected to improve sample transportation and analytical timelines for companies in regions such as Seattle, the San Francisco Bay Area, and San Diego.
Located at OHSU, the facility will utilize a Biosafety Level 2 (BSL-2) laboratory capable of processing a variety of samples, including Adeno-Associated Virus (AAV), lentiviral vectors, lipid nanoparticles (LNPs), and other nanoparticle-based products. OHSU’s microscopy scientists will handle sample preparation and TEM imaging, following QuTEM’s established protocols. The image data will then be securely transferred to QuTEM’s Stockholm headquarters for analysis using its proprietary Gridsee software, assessing critical quality attributes like particle morphology and size distribution.
Josefina Nilsson, CEO of QuTEM AB, stated that the expansion into Portland was driven by requests from regional clients seeking the same satellite laboratory model available in Boston. The collaboration with OHSU is structured through its core service model, with QuTEM utilizing MMC’s equipment and specialist personnel on a fee-for-service basis, while maintaining responsibility for image analysis and quality review.
By offering domestic processing, QuTEM aims to minimize risks associated with international shipping such as temperature changes and customs delays. The Portland laboratory is now open for U.S. projects, providing research and development analysis and support for programs moving toward GMP release testing. Developers interested in these services can contact QuTEM for more information.
About QuTEM
QuTEM AB is a Stockholm-based provider of GMP-certified TEM services and quality control analysis of nanoparticles. It serves biopharmaceutical companies developing AAV, LNP and other viral vector-based therapies. The QuTEM team builds on almost twenty years of hands-on electron microscopy experience. It combines latest-generation instruments with Gridsee, its in-house image analysis software, and validated methods to deliver objective, reproducible data from early research through GMP release. With satellite laboratories in Boston and Portland, QuTEM supports developers in Europe and across the United States.
About the OHSU Multiscale Microscopy Core
The Multiscale Microscopy Core (MMC) at Oregon Health & Science University provides academic and commercial users with access to advanced electron microscopy platforms, together with project consultation, specimen preparation, imaging and analysis services. The core was established in 2013 and is housed in the OHSU’s Robertson Life Sciences Building in Portland, Oregon. Its instruments include a Glacios cryo-transmission electron microscope, a Talos 120C G2 transmission electron microscope, a Helios UC5 Focused Ion Beam scanning electron microscope (FIB-SEM) with cryo capabilities, a Helios G3 FIB-SEM and an Apreo Volume Scope Serial Block face SEM. The MMC is a member of the OHSU University Shared Resource Cores.
Jingyi Zhang
QUTEM AB
Legal Disclaimer:
The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.